Background: Chronic inflammation and chromosome aneuploidy are major traits of primary
STATEMENT OF SIGNIFICANCE
Genomic heterogeneity contributes to therapeutic failure and poor outcome in patients with liver cancer and poses a challenge in defining targeted therapy. Our findings demonstrate an ability to define genomic heterogeneity and corresponding tumor biology of liver cancer based only on bulk genomic and transcriptomic data. Our data also provide a rationale for applying this approach to survey liver tumor immunity and to stratify patients for immune-based therapy. . Genomic instability and chromosome aneuploidy, two main cancer hallmarks found in human solid tumors 14 , may be primary sources of cancer genomic diversity, which enable cancer cells to acquire mutations required for tumor fitness during carcinogenesis. Consequently, diverse tumor cell subpopulations are generated, resulting in both inter-tumor and intra-tumor heterogeneities (ITH) 15 . We hypothesized that the ability of a premalignant cell to acquire genomic instability and chromosomal aneuploidy, giving rise to a more advanced tumor lesion, may determine the extent of ITH. Thus, a solid tumor mass with increased genomic complexity enriched with known hallmarks of cancer may determine its aggressiveness. Furthermore, recent genomic analysis at the single cell resolution indicates that aneuploidy occurs early in tumor evolution and may lead to extensive clonal diversity 16 . However, a majority of genes in the loci
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In this study, we derived FGC in individual tumor based on the newly defined method and determined whether it is correlated with the degree of tumor aggressiveness in HCC and iCCA.
RESULTS

Patient correlation coefficient (PCC) defines functional genomic complexity (FGC)
Since it is generally accepted that somatic copy number alteration (SCNA)-dependent transcriptomic deregulation plays functional driver roles in cancer progression, we hypothesized that the estimate of the SCNA-dependency of transcripts for each patient may reflect genomic complexity with functional influence. We postulated that the SCNA-dependency of transcripts in individual sample could be estimated based on the correlation between SCNAs and their corresponding transcriptome among the globally correlated features. For this, we first performed global correlation analysis between transcriptome and DNA copy number in the TIGER-LC cohort 4 and selected significantly correlated features using a conservative approach (Methods and Fig 1A) . In the overall distribution of global correlation estimates, we found a shift towards positive correlation of the tumor (T) (shaded curves) samples of Thai HCC and iCCA, compared to their corresponding non-tumor (NT) specimens (dotted areas) ( Figure S1A -B, left panels). A positive correlation was more apparent in T samples than NT samples when we compared correlation coefficient value among the selected features (Methods and Figure S1A -B, right panels), indicating that molecular features associated with SCNA-dependent transcripts are tumor-specific. Using these features, we computed PCC per sample (Methods and Table S1a-S1c). To determine the biological relevance of the PCC with genomic complexity, we examined the PCC associated genes (Fig 1B) . Briefly, we performed correlation analysis between PCC and all the transcriptome features and selected positively or negatively associated genes based on the 6 correlation estimate and p-value (above top 5% or below bottom 5% of correlation estimate and p-value < 0.05). Gene Ontology (GO) analysis revealed that DNA repair and cell cycle related biological processes are enriched by PCC positively-associated genes, while immune response pathways are enriched by PCC negatively-associated genes (Fig 1C) . Consistent results were also found when we analyzed Thai HCC and iCCA separately as well as TCGA HCC ( Figure   S2A -F). Since most of over-represented processes were closely related with aneuploidy and chromosomal instability, such as cell cycle and DNA damage response (DDR), we determined the association of PCC with chromosomal instability (CIN) score, which was calculated based on the copy number data only (Supplementary Materials and Methods and Table S1a-S1b). As expected, we observed a strong association between CIN and PCC ( Fig 1D and Figure S3A -C).
Consistent results were also obtained when we compared the genomic instability (GIN) scores, the length of chromosomes with SCNA (Supplementary Materials and Methods and Table S1a ), as another estimate of genomic instability. We found a strong correlation between overall GIN scores and PCC values ( Figure S3D -E). In addition, we found no evidence of preferential allelic gain or loss linked to PCC, when we compared the association of PCC with the amplified (CIN ampl ) and deleted (CIN del ) scores for individual samples (Supplementary Materials and Methods and Figure S4A -B). Interestingly, we found a strong association between CIN ampl and CIN del in both Thai HCC and iCCA ( Figure S4C-D) . Consistent trends were also observed in the broad chromosomal arm-level SCNA analyses in HCC and iCCA when we used the GISTIC 2.0 algorithm ( Figure S4E-F) . These results suggest that gains or losses of specific chromosomal regions may be a consequence of tumor cells acquiring genomic instability and then being selected during tumor evolution. However, it is likely that a majority of genes in the loci with aneuploidy may be passengers. Therefore, we determined whether the PCC also reflected the 7 aneuploidy of the genes with functional role. For this, we compared the PCC with the estimate of total functional aneuploidy (tFA) (Table S1a-1b) 18 , which was inferred from transcriptome data only. Briefly, we calculated tFA in each sample based on the coordinated aberrations in the expression of genes, which were localized to each chromosomal region, by adapting the method in Carter's paper 18 . Since tFA was the estimate of the aneuploidy reflected transcriptome level and more likely to be functional, we examined the functional relevance between PCC and tFA.
In the comparison of GO analysis performed with significantly tFA associated genes, we found functional similarity of PCC ( Figure S5A-F) . Also, we found a strong association of PCC with tFA in TIGER-LC cohort ( Fig 1E) . A strong association maintained when Thai HCC and iCCA were examined separately as well as TCGA HCC ( Figure S5G -I). Moreover, we found a high concordance among CIN, tFA and PCC scores ( Fig 1F and Figure S6 ). Since immune response pathways were enriched by PCC negatively-associated genes, we examined the relevance of PCC with cancer immunity. Many studies have been reported the association of anti-tumor activities of effector T cells at the tumor sites with patient prognosis in solid tumor 19, 20 , we focused on the immune effector activity of the local immune infiltrates. For this, we calculated immune cytolytic activity (ICYT) based on the transcript levels of two key cytolytic effectors, granzyme A (GZMA) and perforin (PRF1) 21 . Consistent with the GO analysis with negatively PCC associated genes, we found a strong inverse correlation between ICYT and PCC in the tumor tissues. However, there was no association in adjacent non-tumor tissues in Thai HCC and iCCA (Fig 1G-H Table S1a ) and found a significant difference in overall survival between HFGC and LFGC, with HFGC being more aggressive than LFGC (Fig 2B) . It was noted that more HCC cases were found in HFGC whereas more iCCA cases were found in LFGC (Fig 2A, right (Fig 2F) . Interestingly, the total number of peak segments was noticeably higher in HCC HFGC than iCCA HFGC ( Figure S9G ). We found more deleted segments with LOH (DEL W/LOH) than amplified segments with LOH (AMP W/LOH).
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Furthermore, the regions for copy neutral LOH (CN LOH), i.e., segments with LOH without SCNA, were only found in HFGC in HCC and iCCA ( Figure S9H , upper panel). Moreover, CN LOH was distributed throughout all genomic regions of iCCA HFGC, while focal enrichment of CN LOH in specific chromosomal arms was found in HCC HFGC ( Figure S9H , lower panel).
Considering the likelihood of CN LOH to activate oncogenes and to unmask tumor suppressers 22 , the high incidence of CN LOH in the HFGC subtype implies a strong contribution of genomic instability to carcinogenesis.
Determination of candidate drivers based on the differentially expressed genes (DEGs) between HFGC and LFGC
To determine additional candidate drivers of HCC and iCCA, we selected DEGs between HFGC and LFGC (permutation t-test p< 0.005 and fold change > 0.5) among the globally correlated genes (Fig 3A-B) . We found that the upregulated genes in HFGC were significantly enriched by cell cycle and DNA replication process-related genes, while immune response-related genes were down-regulated (Fig 3C-E and Table S2) , with similar results found in TCGA HCC ( Figure   S10A -B and Table S3) Table S6 ). These results suggest that tumor biology may differ between HFGC and LFGC regardless of PLC tumor type (Table S7 ).
1 0
TP53 mutations are associated with increased FGC in PLC
Next, we examined whether specific gene mutations are associated with FGC. A total of 100 mutated genes were commonly found in HCC and iCCA (Table S8- Figure S12B , and Table S11 ). Interestingly, TP53 mutations at the DBD regions, including the most frequent R249S mutation in HCC, were more frequent in HFGC than LFGC tumors (Fig 4B, Figure S12B and S12E). Moreover, Thai HCC and iCCA cases with TP53 mutations had a much worse survival than those with wild type p53 ( Fig 4C-D) with comparable results found in TCGA HCC cases ( Fig 4E) . Since TP53 DBD mutations are considered as a gain-of-function mutant p53 protein (mutp53) involved in the maintenance of genome integrity [23] [24] [25] [26] , it is plausible that the TP53 mutations may result in increased genomic instability, leading to elevated FGC scores. Indeed, cases with TP53 mutation were significantly enriched in HFGC (Fig 4F and Table S12 ). Also, patients with TP53 mutation showed much higher CIN and FGC than wild type p53 ( Fig 4G-H , Figure S12C -D, and S12F-G).
Taken together, we suggest that tumors with higher FGC scores may originate from genomic instability due to p53 mutations, leading to carcinogenesis.
Association between FGC and Tumor infiltrating lymphocytes (TILs) in PLC
To analyze the extent of tumor infiltrating lymphocytes (TILs) in the TIGER-LC cohort, we cancer [29] [30] [31] [32] . Also, we found that PDCD1LG2 (PD-L2), ligand for PD-1, was up-regulated in LFGC compared to HFGC indicative of the sensitivity to the immune-checkpoint inhibitor (ICI) 33 .
FGC may be useful to predict patients' responses to ICI-based immunotherapy.
Also, to examine whether increased FGC may be associated with ICI response, we analyzed the TCGA melanoma dataset as liver cancer-related ICI dataset is not available 34 . To infer the FGC level in each patient, we calculated tFA as a surrogate for FGC. Consistently, we found that high tFA was correlated with poor survival in melanoma cohort ( Figure S14E and Table S13a ). Since patients who were treated with anti-CTLA-4 therapy were included in the TCGA melanoma dataset, we performed the Kaplan-Meier (KM) survival analysis by excluding them separately (Supplementary Materials and Methods) and found similar result ( Figure S14F ). Besides, the tFA level of the non-responders to the anti-CTLA-4 therapy was much higher compared to responders ( Figure S14G ), suggesting that the tFA level was closely associated with the efficacy of anti-CLTA-4 therapy. Similar trends were found in the analysis performed in the cohort of patients with metastatic melanoma who were treated with anti-PD-1 immunotherapy 35 ( Figure   S14H and Table S13b ). Overall, these results indicate that FGC could be useful to predict patients' responses to ICI-based immunotherapy.
DISCUSSION
PLC is clinically and molecularly heterogeneous and is highly refractory to treatment. The extensive heterogeneity of PLC may be due to the presence of complex etiological factors that causes chronic liver diseases. A common denominator at its origin is a perpetual wound-healing 1 3
response triggered by parenchymal cell death, with an ensuing inflammatory cascade and concomitant fibrosis progression 36 . In addition, inflammation-induced replication stress promotes DNA damage, which subsequently induces DDR, genomic instability and finally tumorigenesis 37 . Thus, we hypothesized that chronic inflammation may be the main initiator of hepatocarcinogenesis through induction of genomic instability and aneuploidy. Consistently, TP53 mutations may be a key driver for inflammatory-mediated hepatocarcinogenesis since it is the most frequently mutated gene in PLC 38 . We found PLC cases with increased FGC enrich for relevance of immunotherapy 43 . In addition, checkpoint inhibitor-based immunotherapies targeting the regulatory pathways of T cells, cytotoxic T-lymphocyte associated antigen 4 (CTLA-4) (ipilimumab) and programmed cell death protein 1 (PD-1) (e.g., nivolumab or pembrolizumab), have enhanced anti-tumor activity with significant clinical benefit in patients with various cancers 44 including HCC 45 . While it is unclear why most HCC patients do not benefit from immunotherapy, an ineffective immune surveillance program due to immunosuppressive mechanisms that are functional in tumor cells or the tumor-educated liver microenvironment has been suggested. Moreover, it has been difficult to identify predictive biomarkers of response to these agents. Our results show that the FGC score can distinguish TIL subpopulations associated with genomic instability. Therefore, we suggest that an FGC score may be a simple and reliable predictive indicator to stratify patients for immune therapy using only bulk genomic and transcriptomic analysis.
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The CIN (G) and FGC (H) level between TP53 WT and TP53 mutation among Thai HCC. Pvalues based on the Welch two-sample t-test were depicted. NSYN, non-synonymous mutation;
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